Company Overview
Siegfried is a globally leading contract and development manufacturing organization, producing pharmaceutical ingredients and finished products as an integrated supplier. We offer contract developing and manufacturing of active pharmaceutical ingredients, intermediates, and finished dosage forms. Our integrated approach ensures that we can provide a range of services, from process development and optimization to registration, production, packaging, and logistics. Global Presence
Siegfried counts on a global network of 13 facilities in seven countries on three continents for the production of active pharmaceutical ingredients and intermediates (Drug Substances) and finished dosage forms (Drug Products). Mission and Impact
Siegfried supplies approximately 200 out of 1500 APIs approved by the FDA. We serve more than 500 customers globally, and up to one billion people come in contact with Siegfried products every year. Over 100 million doses of Covid-19 vaccines have been manufactured by Siegfried. Sustainability Efforts
We are committed to reducing our carbon footprint in close collaboration with our customers. With our expertise in process optimization, we help our customers to develop greener production processes, which require less energy and produce less waste while maximizing the safety of our products. Siegfried is a member of the Dow Jones Best-In-Class Europe Index (formerly Dow Jones Sustainability Index Europe) and rated AA by MSCI. COMPANY HISTORY
Founded in 1873 by pharmacist Samuel Benoni Siegfried in Zofingen, Switzerland, the company has been growing steadily ever since. Siegfried evolved into a global player with state-of-the-art facilities and cutting-edge technologies through strategic acquisitions.
#J-18808-Ljbffr